HomeMEHCQ • OTCMKTS
add
23andMe Holding Co.
Previous close
$1.04
Day range
$1.04 - $1.51
Year range
$0.48 - $12.76
Market cap
35.01M USD
Avg Volume
8.08M
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 60.26M | 34.67% |
Operating expense | 65.06M | -22.18% |
Net income | -53.04M | 80.92% |
Net profit margin | -88.01 | 85.83% |
Earnings per share | — | — |
EBITDA | -21.80M | 62.70% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 79.35M | -67.27% |
Total assets | 277.42M | -54.39% |
Total liabilities | 214.70M | -7.06% |
Total equity | 62.72M | — |
Shares outstanding | 26.83M | — |
Price to book | 0.44 | — |
Return on assets | -21.15% | — |
Return on capital | -42.49% | — |
Cash Flow
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -53.04M | 80.92% |
Cash from operations | -44.65M | -270.23% |
Cash from investing | 887.00K | 144.09% |
Cash from financing | -19.00K | -118.10% |
Net change in cash | -43.79M | -213.47% |
Free cash flow | -20.18M | -469.10% |
About
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Founded
Apr 2006
Headquarters
Website
Employees
571